{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:17:01Z","timestamp":1759529821836,"version":"3.38.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T00:00:00Z","timestamp":1291248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1038\/hr.2010.229","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T07:12:54Z","timestamp":1291273974000},"page":"341-347","source":"Crossref","is-referenced-by-count":24,"title":["Simvastatin prevents large blood pressure variability induced aggravation of cardiac hypertrophy in hypertensive rats by inhibiting RhoA\/Ras\u2013ERK pathways"],"prefix":"10.1038","volume":"34","author":[{"given":"Narimasa","family":"Takayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Yasuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Anegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhisa","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Kajimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,12,2]]},"reference":[{"key":"BFhr2010229_CR1","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1291\/hypres.31.1491","volume":"31","author":"Y Yano","year":"2008","unstructured":"Yano Y, Kario K . Unresolved issues of the morning blood pressure surge: the next stage of clinical applicability for the morning surge. Hypertens Res 2008; 31: 1491\u20131494.","journal-title":"Hypertens Res"},{"key":"BFhr2010229_CR2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/hr.2010.70","volume":"33","author":"H Metoki","year":"2010","unstructured":"Metoki H, Ohkubo T, Imai Y . Diurnal blood pressure variation and cardiovascular prognosis in a community-based study of Ohasama, Japan. Hypertens Res 2010; 33: 652\u2013656.","journal-title":"Hypertens Res"},{"key":"BFhr2010229_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/01.RES.53.1.96","volume":"53","author":"G Mancia","year":"1983","unstructured":"Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A . Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983; 53: 96\u2013104.","journal-title":"Circ Res"},{"key":"BFhr2010229_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/01.HYP.11.3.273","volume":"11","author":"JS Floras","year":"1988","unstructured":"Floras JS, Hassan MO, Jones JV, Osikowska BA, Sever PS, Sleight P . Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertension 1988; 11: 273\u2013281.","journal-title":"Hypertension"},{"key":"BFhr2010229_CR5","first-page":"405","volume":"4","author":"V Canonico","year":"1990","unstructured":"Canonico V, De Caprio L, Vigorito C, Forgione L, Tedeschi C, Guarini P, Rengo F . Differences in blood pressure profile between young and elderly hypertensive patients. J Hum Hypertens 1990; 4: 405\u2013409.","journal-title":"J Hum Hypertens"},{"key":"BFhr2010229_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1161\/01.HYP.0000158306.87582.43","volume":"45","author":"NA Zakopoulos","year":"2005","unstructured":"Zakopoulos NA, Tsivgoulis G, Barlas G, Papamichael C, Spengos K, Manios E, Ikonomidis I, Kotsis V, Spiliopoulou I, Vemmos K, Mavrikakis M, Moulopoulos SD . Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005; 45: 505\u2013512.","journal-title":"Hypertension"},{"key":"BFhr2010229_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00004872-198702000-00013","volume":"5","author":"G Parati","year":"1987","unstructured":"Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G . Relationship of 24-h blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5: 93\u201398.","journal-title":"J Hypertens"},{"key":"BFhr2010229_CR8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1161\/hy0202.104376","volume":"39","author":"R Sega","year":"2002","unstructured":"Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, Ferrario M, Mancia G . Blood pressure variability and organ damage in a general population: Results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 2002; 39: 710\u2013714.","journal-title":"Hypertension"},{"key":"BFhr2010229_CR9","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1291\/hypres.31.2137","volume":"31","author":"A Tatasciore","year":"2009","unstructured":"Tatasciore A, Zimarino M, Renda G, Zurro M, Soccio M, Prontera C, Emdin M, Flacco M, Schillaci G, De Caterina R . Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res 2009; 31: 2137\u20132146.","journal-title":"Hypertens Res"},{"key":"BFhr2010229_CR10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1161\/01.HYP.36.5.901","volume":"36","author":"M Kikuya","year":"2000","unstructured":"Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michimata M, Matsubara M, Ota M, Nagai K, Araki T, Satoh H, Ito S, Hisamichi S, Imai Y . Prognostic significance of blood pressure and heart rate variabilities: The Ohasama study. Hypertension 2000; 36: 901\u2013906.","journal-title":"Hypertension"},{"key":"BFhr2010229_CR11","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1097\/00004872-200312000-00012","volume":"21","author":"E Pringle","year":"2003","unstructured":"Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, de Leeuw PW, Jaaskivi M, Nachev C, Parati G, O\u2019Brien ET, Tuomilehto J, Webster J, Bulpitt CJ, Fagard RH . Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertension 2003; 21: 2251\u20132257.","journal-title":"J Hypertension"},{"key":"BFhr2010229_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1291\/hypres.28.1","volume":"28","author":"M Eto","year":"2005","unstructured":"Eto M, Toba K, Akishita M, Kozaki K, Watanabe T, Kim S, Hashimoto M, Ako J, Iijima K, Sudoh N, Yoshizumi M, Ouchi Y . Impact of blood pressure variability on cardiovascular events in elderly patients with hypertension. Hypertens Res 2005; 28: 1\u20137.","journal-title":"Hypertens Res"},{"key":"BFhr2010229_CR13","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1161\/HYPERTENSIONAHA.109.135905","volume":"54","author":"H Kudo","year":"2009","unstructured":"Kudo H, Kai H, Kajimoto H, Koga M, Takayama N, Mori T, Ikeda A, Yasuoka S, Angawa T, Mifune H, Kato S, Hirooka H, Imaizumi T . Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation. Hypertension 2009; 54: 832\u2013838.","journal-title":"Hypertension"},{"key":"BFhr2010229_CR14","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1253\/circj.CJ-09-0741","volume":"73","author":"H Kai","year":"2009","unstructured":"Kai H, Kudo H, Takayama N, Yasuoka S, Kajimoto H, imaizumi T . Large blood pressure variability and hypertensive cardiac remodeling -Role of cardiac inflammation-. Circ J 2009; 73: 2198\u20132203.","journal-title":"Circ J"},{"key":"BFhr2010229_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/jim-52-04-33","volume":"52","author":"JK Liao","year":"2004","unstructured":"Liao JK . Statin therapy for cardiac hypertrophy and heart failure. J Investig Med 2004; 52: 248\u2013253.","journal-title":"J Investig Med"},{"key":"BFhr2010229_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jacc.2007.10.009","volume":"51","author":"K Ramasubbu","year":"2008","unstructured":"Ramasubbu K, Estep J, White DL, Deswal A, Mann DL . Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol 2008; 51: 415\u2013426.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr2010229_CR17","doi-asserted-by":"publisher","first-page":"31185","DOI":"10.1074\/jbc.271.49.31185","volume":"271","author":"VP Sah","year":"1996","unstructured":"Sah VP, Hoshijima M, Chien KR, Brown JH . Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways. J Biol Chem 1996; 271: 31185\u201331190.","journal-title":"J Biol Chem"},{"key":"BFhr2010229_CR18","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI13350","volume":"108","author":"M Takemoto","year":"2001","unstructured":"Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, Takemoto Y, Kitakaze M, Liao JK . Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 2001; 108: 1429\u20131437.","journal-title":"J Clin Invest"},{"key":"BFhr2010229_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1161\/01.RES.0000096650.91688.28","volume":"93","author":"M Higashi","year":"2003","unstructured":"Higashi M, Shimokawa H, Hattori T, Hiroki J, Mukai Y, Morikawa K, Ichiki T, Takahashi S, Takeshita A . Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: Effect on endothelial NAD(P)H oxidase system. Circ Res 2003; 93: 767\u2013775.","journal-title":"Circ Res"},{"key":"BFhr2010229_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0165-6147(97)01147-4","volume":"19","author":"BA Hamelin","year":"1998","unstructured":"Hamelin BA, Turgeon J . Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol Sci 1998; 19: 26\u201337.","journal-title":"Trends Pharmacol Sci"},{"key":"BFhr2010229_CR21","doi-asserted-by":"publisher","first-page":"H938","DOI":"10.1152\/ajpheart.01097.2002","volume":"285","author":"RE Girgis","year":"2003","unstructured":"Girgis RE, Li D, Zhan X, Garcia JG, Tuder RM, Hassoun PM, Johns RA . Attenuation of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Heart Circ Physiol 2003; 285: H938\u2013H945.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr2010229_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/01.RES.15.6.511","volume":"15","author":"EM Krieger","year":"1964","unstructured":"Krieger EM . Neurogenic hypertension in rat. Circ Res 1964; 15: 511\u2013521.","journal-title":"Circ Res"},{"key":"BFhr2010229_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","volume":"106","author":"F Kuwahara","year":"2002","unstructured":"Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaizumi T . Transforming growth factor-\u03b2 function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002; 106: 130\u2013135.","journal-title":"Circulation"},{"key":"BFhr2010229_CR24","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.RES.83.6.594","volume":"83","author":"H Kai","year":"1998","unstructured":"Kai H, Muraishi A, Sugiu Y, Nishi H, Seki Y, Kuwahara F, Kimura A, Kato H, Imaizumi T . Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy. Circ Res 1998; 83: 594\u2013601.","journal-title":"Circ Res"},{"key":"BFhr2010229_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.HYP.0000111831.50834.93","volume":"43","author":"K Tokuda","year":"2004","unstructured":"Tokuda K, Kai H, Kuwahara F, Yasukawa H, Tahara N, Kudo H, Takemiya K, Koga M, Yamamoto T, Imaizumi T . Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis. Hypertension 2004; 43: 499\u2013503.","journal-title":"Hypertension"},{"key":"BFhr2010229_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/01.HYP.0000259668.37901.8c","volume":"49","author":"K Kusaba","year":"2007","unstructured":"Kusaba K, Kai H, Koga M, Takayama N, Ikeda A, Yasukawa H, Seki Y, Egashira K, Imaizumi T . Inhibition of intrinsic interferon-\u03b3 function prevents neointima formation after balloon injury. Hypertension 2007; 49: 909\u2013915.","journal-title":"Hypertension"},{"key":"BFhr2010229_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1161\/CIRCRESAHA.106.147256","volume":"101","author":"M Koga","year":"2007","unstructured":"Koga M, Kai H, Yasukawa H, Yamamoto T, Kawai Y, Kato S, Kusaba K, Kai M, Egashira K, Kataoka Y, Imaizumi T . Inhibition of progression and stabilization of plaques by therapeutic interferon-\u03b3 function blocking in ApoE-KO mice. Circ Res 2007; 101: 348\u2013356.","journal-title":"Circ Res"},{"key":"BFhr2010229_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/01.HYP.24.4.523","volume":"24","author":"H Kai","year":"1994","unstructured":"Kai H, Griendling KK, Lassegue B, Ollerenshaw JD, Runge MS, Alexander RW . Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptors. Hypertension 1994; 24: 523\u2013527.","journal-title":"Hypertension"},{"key":"BFhr2010229_CR29","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1089\/hum.2004.15.1270","volume":"15","author":"N Tahara","year":"2004","unstructured":"Tahara N, Kai H, Niiyama H, Mori T, Sugi Y, Takayama N, Yasukawa H, Numaguchi Y, Matsui H, Okamura K, Imaizumi T . Repeated gene transfers of naked prostacyclin synthase plasmid into skeletal muscles attenuate monocrotaline-induced pulmonary hypertension and prolong survival in rats. Human Gene Ther 2004; 15: 1270\u20131278.","journal-title":"Human Gene Ther"},{"key":"BFhr2010229_CR30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0026-895X(25)08699-7","volume":"49","author":"H Kai","year":"1996","unstructured":"Kai H, Griendling KK, Lass\u00e8gue B, Fukui T, Minieri CA, Alexander RW . Prolonged exposure to agonist results in a reduction in the levels of the Gq\/G11 \u03b1-subunit in cultured vascular smooth muscle cells. Mol Pharmacol 1996; 49: 96\u2013104.","journal-title":"Mol Pharmacol"},{"key":"BFhr2010229_CR31","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1161\/01.CIR.0000034047.70205.97","volume":"106","author":"C Indolfi","year":"2002","unstructured":"Indolfi C, Di Lorenzo E, Perrino C, Stingone AM, Curcio A, Torella D, Cittadini A, Cardone L, Coppola C, Cavuto L, Arcucci O, Sacca L, Avvedimento EV, Chiariello M . Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation. Circulation 2002; 106: 2118\u20132124.","journal-title":"Circulation"},{"key":"BFhr2010229_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1161\/01.RES.84.6.633","volume":"84","author":"PH Sugden","year":"1999","unstructured":"Sugden PH . Signaling in myocardial hypertrophy: Life after calcineurin? Circ Res 1999; 84: 633\u2013646.","journal-title":"Circ Res"},{"key":"BFhr2010229_CR33","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/01.RES.0000216039.75913.9e","volume":"98","author":"JH Brown","year":"2006","unstructured":"Brown JH, Del Re DP, Sussman MA . The Rac and Rho hall of frame: A decade of hypertrophic signaling hits. Circ Res 2006; 98: 730\u2013742.","journal-title":"Circ Res"},{"key":"BFhr2010229_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1161\/01.RES.84.4.458","volume":"84","author":"R Aikawa","year":"1999","unstructured":"Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Zhu W, Kadowaki T, Yazaki Y . Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes. Circ Res 1999; 84: 458\u2013466.","journal-title":"Circ Res"},{"key":"BFhr2010229_CR35","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1093\/emboj\/16.8.1888","volume":"16","author":"J Thorburn","year":"1997","unstructured":"Thorburn J, Xu S, Thorburn A . MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J 1997; 16: 1888\u20131900.","journal-title":"EMBO J"},{"key":"BFhr2010229_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/cvr\/27.3.341","volume":"27","author":"KT Weber","year":"1993","unstructured":"Weber KT, Brilla CG, Janicki JS . Myocardial fibrosis: Functional significance and regulatory factors. Cardiovasc Res 1993; 27: 341\u2013348.","journal-title":"Cardiovasc Res"},{"key":"BFhr2010229_CR37","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/S0008-6363(98)00305-8","volume":"41","author":"A Nicoletti","year":"1999","unstructured":"Nicoletti A, Michel JB . Cardiac fibrosis and inflammation: Interaction with hemodynamic and hormonal factors. Cardiovasc Res 1999; 41: 532\u2013543.","journal-title":"Cardiovasc Res"},{"key":"BFhr2010229_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev.physiol.59.1.551","volume":"59","author":"J Sadoshima","year":"1997","unstructured":"Sadoshima J, Izumi S . The cellular and molecular response of cardiac mypcytes to mechanical stress. Annu Rev Physiol 1997; 59: 551\u2013571.","journal-title":"Annu Rev Physiol"},{"key":"BFhr2010229_CR39","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1161\/01.CIR.97.19.1952","volume":"97","author":"K Harada","year":"1999","unstructured":"Harada K, Komuro I, Shiojima I, Hayashi D, Kudoh S, Mizuno T, Kijima K, Matsubara H, Sugaya T, Murakami K, Yazaki Y . Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation 1999; 97: 1952\u20131959.","journal-title":"Circulation"},{"key":"BFhr2010229_CR40","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/cvr\/26.7.671","volume":"26","author":"CG Brilla","year":"1992","unstructured":"Brilla CG, Weber KT . Reactive and reparative myocardial fibrosis in arterial hypertension in the rats. Cardiovasc Res 1992; 26: 671\u2013677.","journal-title":"Cardiovasc Res"},{"key":"BFhr2010229_CR41","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0008-6363(96)00158-7","volume":"32","author":"A Nicoletti","year":"1996","unstructured":"Nicoletti A, Heudes D, Mandet C, Hinglais N, Bariety J, Michel JB . Inflammatory cells and myocardial fibrosis: Spatial and temporal distribution in renovascular hypertensive rats. Cardiovasc Res 1996; 32: 1096\u20131107.","journal-title":"Cardiovasc Res"},{"key":"BFhr2010229_CR42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/01.HYP.0000118584.33350.7d","volume":"43","author":"F Kuwahara","year":"2004","unstructured":"Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T . Hypertensive myocardial fibrosis and diastolic dysfunction -Another model of inflammation-. Hypertension 2004; 43: 739\u2013745.","journal-title":"Hypertension"},{"key":"BFhr2010229_CR43","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1161\/01.RES.82.6.666","volume":"82","author":"H Aoki","year":"1998","unstructured":"Aoki H, Izumo S, Sadoshima J . Angiotensin II activates RhoA in cardiac myocytes: A critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res 1998; 82: 666\u2013676.","journal-title":"Circ Res"},{"key":"BFhr2010229_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/01.HYP.0000024348.87637.6F","volume":"40","author":"S Delbosc","year":"2002","unstructured":"Delbosc S, Cristol JP, Descomps B, Mimran A, Jover B . Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress. Hypertension 2002; 40: 142\u2013147.","journal-title":"Hypertension"},{"key":"BFhr2010229_CR45","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1161\/01.CIR.100.21.2131","volume":"100","author":"G Nickenig","year":"1999","unstructured":"Nickenig G, B\u00e4umer AT, Temur Y, Kebben D, Jockenh\u00f6vel F, B\u00f6hm M . Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation 1999; 100: 2131\u20132141.","journal-title":"Circulation"},{"key":"BFhr2010229_CR46","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1124\/mol.59.3.646","volume":"59","author":"S Wassmann","year":"2001","unstructured":"Wassmann S, Laufs U, B\u00e4umer AT, M\u00fcller K, Konkol C, Sauer H, B\u00f6hm M, Nickenig G . Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: Involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol 2001; 59: 646\u2013654.","journal-title":"Mol Pharmacol"},{"key":"BFhr2010229_CR47","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/j.1440-1681.2006.04508.x","volume":"33","author":"M Saka","year":"2006","unstructured":"Saka M, Obata K, Ichihara S, Cheng XW, Kimata H, Noda A, Izawa H, Nagata K, Yokota M . Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: Potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway. Clin Exp Pharmacol Physiol 2006; 33: 1164\u20131171.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFhr2010229_CR48","first-page":"904","volume":"47","author":"T Aoki","year":"1997","unstructured":"Aoki T, Nishimura H, Nakagawa S, Kojima J, Suzuki H, Tamaki T, Wada Y, Yokoo N, Sato F, Kimata H, Kitahara M, Toyoda K, Sakashita M, Saito Y . Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Arzneimittelforschung 1997; 47: 904\u2013909.","journal-title":"Arzneimittelforschung"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2010229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010229","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2010229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T10:58:41Z","timestamp":1740740321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2010229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,2]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["BFhr2010229"],"URL":"https:\/\/doi.org\/10.1038\/hr.2010.229","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"type":"print","value":"0916-9636"},{"type":"electronic","value":"1348-4214"}],"subject":[],"published":{"date-parts":[[2010,12,2]]}}}